Study at SLEEP 2024 finds low-dose aspirin reduces inflammation during sleep loss.
A study at SLEEP 2024 reveals that low-dose aspirin may reduce inflammation during sleep loss. Researchers from Harvard Medical School found that preemptive administration of low-dose aspirin during sleep restriction reduced pro-inflammatory responses, including interleukin-6 expression and C-reactive protein serum levels. The study involving 46 healthy adults suggests that low-dose aspirin could help blunt inflammatory pathways activated by sleep restriction, potentially leading to new therapeutics for those experiencing periods of sleep deficiency.
June 03, 2024
9 Articles